Shareholders Approve Broad Equity Issuance Authority and Share Buyback Program Amid Dissent
CRTO sits 20% above its 52-week low of $15.575.
Summary
Criteo shareholders approved broad authority for the Board to issue new shares and conduct buybacks, with significant dissent on equity-related proposals.
Key Events · Corporate Governance and Compliance · CRTO
-
Broad Equity Issuance Authority Approved
Shareholders delegated authority to the Board to increase share capital through various means, including public offerings and grants of options and RSUs. This includes the approval of overall limits for these capital increases, which were previously indicated to potentially lead to approximately 14% dilution. Notably, resolutions for granting options and increasing capital without preferential rights faced over 20% 'Against' votes.
-
Share Buyback Program Re-Authorized
The Board was re-authorized to execute a buyback of company stock and reduce share capital by canceling repurchased shares. This continues an existing program aimed at returning capital to shareholders.
-
Executive Compensation Approved with Dissent
The non-binding advisory vote on executive compensation was approved, but with approximately 17% of votes cast against the proposal, indicating notable shareholder dissatisfaction.
-
Bylaw Amendment for Record Date
An amendment to the company's by-laws was approved to comply with new French Commercial Code provisions, changing the record date for shareholder meetings from two to five business days prior to the meeting.
Analysis · CRTO · Trade & Services
Criteo's shareholders approved several key proposals at the Annual General Meeting, including significant authorizations for the Board to issue new shares and grant equity awards, which could lead to substantial dilution. This approval, despite notable shareholder dissent (over 20% against certain equity-related proposals), creates an overhang for the stock, especially following the company's recent weak financial performance. While a share buyback program was also re-authorized, the potential for future dilution from new share issuance is a primary concern for investors.
At the time of this filing, CRTO was trading at $18.66 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $884.7M. The 52-week trading range was $15.58 to $26.53. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.